Zhenhao Shi
Research Assistant Professor of Psychiatry
Department: Psychiatry
Contact information
3535 Market St Ste 500
Philadelphia, PA 19104
Philadelphia, PA 19104
Office: 2157461822
Publications
Education:
BS (Psychology)
Peking University, 2009.
PhD (Cognitive Neuroscience)
Peking University, 2014.
BS (Psychology)
Peking University, 2009.
PhD (Cognitive Neuroscience)
Peking University, 2014.
Post-Graduate Training
Postdoctoral Fellow in Health Communication, Annenberg Public Policy Center, University of Pennsylvania, 2014-2016.
Postdoctoral Fellow in Addiction, Center for Studies of Addiction, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, 2016-2021.
Permanent linkPostdoctoral Fellow in Health Communication, Annenberg Public Policy Center, University of Pennsylvania, 2014-2016.
Postdoctoral Fellow in Addiction, Center for Studies of Addiction, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, 2016-2021.
Description of Research Expertise
Brain imaging, Public health, Social neuroscience, Translational neuroscience, Computational psychiatry, Substance use disorder, Tobacco control, Health communication, Cross-cultural psychologySelected Publications
Liu Y, Zhao X, Hu W, Ren Y, Wei Z, Ren X, Tang Z, Wang N, Chen H, Li Y, Shi Z, Qin S, Yang J.: Neural habituation during acute stress signals a blunted endocrine response and poor resilience. Psychol Med Jun 2023.Byanyima JI, Li X, Vesslee SA, Kranzler HR, Shi Z, Wiers CE.: Metabolic Profiles Associated with Opioid Use and Opioid Use Disorder: a Narrative Review of the Literature. Current Addiction Reports May 2023.
Shi Z, Wang AL, Fairchild VP, Aronowitz CA, Padley JH, Lynch KG, Loughead J, Langleben DD.: Effects of emotional arousal on the neural impact and behavioral efficacy of cigarette graphic warning labels. Addiction 118: 914-924, May 2023.
Shi Z, Li X, Kampman KM, Childress AR, Wiers CE, Langleben DD.: Depressive Symptomatology Is Associated With Smaller Reductions in Drug Cue Reactivity During Extended-Release Naltrexone Treatment of Opioid Use Disorder. J Clin Psychiatry 84: 22br14567, Apr 2023.
Shi Z, Wang AL, Fairchild VP, Aronowitz CA, Lynch KG, Loughead J, Langleben DD.: Addicted to green: priming effect of menthol cigarette packaging on brain response to smoking cues. Tob Control 32: e45-e52, Apr 2023.
Shi Z, Li X, Byanyima JI, O'Brien CP, Childress AR, Lynch KG, Loughead J, Wiers CE, Langleben DD.: Effects of current smoking severity on brain gray matter volume in opioid use disorder - a voxel-based morphometry study. Am J Drug Alcohol Abuse 49: 180-189, Mar 2023.
Adams AR, Li X, Byanyima JI, Vesslee SA, Nguyen TD, Wang Y, Moon B, Pond T, Kranzler HR, Witschey WR, Shi Z, Wiers CE.: Peripheral and Central Iron Measures in Alcohol Use Disorder and Aging: A Quantitative Susceptibility Mapping Pilot Study. Int J Mol Sci 24: 4461, Feb 2023.
Li X, Langleben DD, Lynch KG, Wang GJ, Wiers CE, Shi Z: Body mass index as predictor of retention in extended-release naltrexone treatment of opioid use disorder. Poster presentation at the 61st Annual Meeting of the American College of Neuropsychopharmacology, Phoenix, AZ. Page: 0-0, Dec 2022.
Li X, Shi Z, Byanyima J, Morgan PT, van der Veen JW, Zhang R, Deneke E, Wang GJ, Volkow ND, Wiers CE.: Brain glutamate and sleep efficiency associations following a ketogenic diet intervention in individuals with Alcohol Use Disorder. Drug Alcohol Depend Rep 5: 100092, Dec 2022.
Shi Z, Langleben DD, O'Brien CP, Childress AR, Wiers CE.: Multivariate pattern analysis links drug use severity to distributed cortical hypoactivity during emotional inhibitory control in opioid use disorder. Neuroimage Clin 32: 102806, Aug 2021.